CJC-1295 with DAC
cjc dac
Long-acting GHRH analog via Drug Affinity Complex. Weekly dosing rationale, sleep and recovery tracking.
- Half-life
- 7.0 d
- Out of system
- ~5 weeks
- Route
- Subcutaneous
- Level
- Intermediate
Long-acting — weekly dosing keeps levels steady. After the last dose, roughly 97% has cleared in ~5 weeks (five half-lives) — the window that matters for washouts, bloodwork and surgery.
What CJC-1295 with DAC is used for
- Long-acting GHRH analog — sustained baseline GH lift
- Weekly dosing instead of daily injections
- Reported sleep and recovery improvements
How it's typically used
Research range: 1–2 mg subcutaneous once weekly. Often stacked with Ipamorelin.
What to watch for
- Sustained GH elevation can cause water retention, joint aches, glucose changes
- Not pulsatile — diverges from natural GH rhythm
- Avoid with diabetes, sleep apnea, or hormone-sensitive conditions
About Performance & GH
- What they are
- Growth-hormone secretagogues and related performance compounds. Rather than supplying GH, they push your pituitary to release more of its own in a pulse.
- How they're run
- Subcutaneous injection, most often at night on an empty stomach so the pulse lands with natural sleep-driven GH release.
- What to watch
- Water retention, tingling hands, and hunger swings are the common early signs. Raising GH raises IGF-1 — worth tracking on bloodwork, and a reason to avoid these with any cancer history.
Full guide
CJC-1295 with DAC: Tracking the Long-Acting GHRH Analog
A practical tracking guide for the DAC version of CJC-1295, with weekly dosing rationale and IGF-1 expectations.
Other performance & gh
Peptid AI is an educational and self-tracking tool — not a medical service, and not a vendor. Nothing here is medical advice, a prescription, or an endorsement. Doses reflect what is commonly reported in research literature; they are not recommendations. Many compounds listed are experimental, not approved for human use, and/or controlled substances that are illegal to possess without a prescription in many countries. Always consult a qualified physician before starting, changing, or stopping any protocol.